Magdalena Cerdá, DrPH
NYU Langone Health - Professor, Department of Population Health and Department of Emergency Medicine
NYU Langone Health - Director, Center on Opioid Epidemiology and Policy
NYU Langone Health - Director, Center on Opioid Epidemiology and Policy
Education
DrPH, Public Health, Harvard University, School of Public HealthMPH, Public Health, Yale University
BS, Communication, Cornell University, Agriculture and Life Sciences
Research Interests
Opioid use disorder, Violence prevention, Firearms, Prescription drugs, Heroin, Drug overdose, Social determinants of injury, Marijuana, Homicide, Suicide BIO
Magdalena Cerdá is Professor of Population Health at New York University Langone Health and Director of the NYU Center on Opioid Epidemiology and Policy. Her work integrates approaches from social and psychiatric epidemiology to examine how social contexts shape violent behavior, substance use and common forms of mental illness. Her expertise extends to the epidemiology and policy determinants of substance use with a particular focus on opioid and marijuana use, including two NIDA-funded studies to examine the impact that prescription opioid policies and marijuana legalization have on opioid prescribing, chronic pain, and opioid overdoses, and a NIDA-funded study to examine the impact that national marijuana legalization in Uruguay has on substance use. Dr. Cerdá also uses agent-based models to simulate the potential impact of city- and neighborhood-level prevention programs and policies on violence. Prior to joining NYU, Dr. Cerdá served as the Vice-Chancellor’s Endowed Chair on Violence Prevention at UC-Davis and on the faculty at the Columbia Mailman School of Public Health. Dr. Cerdá received her DrPH from Harvard University and was a Robert Wood Johnson Health and Society Scholar at the University of Michigan. Projects
Principal Investigator, Comparative Evaluation of Overdose Prevention Programs in New York City and Rhode Island. Active
Principal Investigator, Examining the Synergistic Effects of Cannabis and Prescription Opioid Policies on Chronic Pain, Opioid Prescribing, and Opioid Overdose. Active
Principal Investigator, Large Data Spatiotemporal Modeling of Optimal Combinations of Interventions to Reduce Opioid Harm in the United States. Active
Principal Investigator, Reducing Drug-Related Mortality Using Predictive Analytics: A Randomized, Statewide, Community Intervention Trial. Active
Principal Investigator, Understanding the Short- and Long-term Effects of the COVID-19 Pandemic on the Overdose Crisis. Active
Principal Investigator, Health and Social Consequences of Marijuana Legalization. Completed
Principal Investigator, Prescription Drug Monitoring Programs and Opioid-Related Harm. Completed
Principal Investigator, Substance Abuse History, Mental Health and Firearm Violence: From Evidence To Action. Completed
Publications
Recent
Rudolph KE, Williams NT, Diaz I, Forrest S, Hoffman KL, Samples H, Olfson M, Doan L, Cerda M, Ross RK (2024).
Pain management treatments and opioid use disorder risk in Medicaid patients
American Journal of Preventive Medicine, 67 (6), 878-886. doi: 10.1016/j.amepre.2024.07.006. PMCID: PMC11585455.
Pain management treatments and opioid use disorder risk in Medicaid patients
American Journal of Preventive Medicine, 67 (6), 878-886. doi: 10.1016/j.amepre.2024.07.006. PMCID: PMC11585455.
Santaella-Tenorio J, Rivera-Aguirre A, Hepler S, Kline D, Cantor J, DeYoreo M, Martins S, Krawczyk N, Cerda M (2024).
Rates of receiving medication for opioid use disorder and opioid overdose deaths during the early synthetic opioid crisis: A county-level analysis
Epidemiology [Epub 2024 Nov 22]. doi: 10.1097/EDE.0000000000001816.
Rates of receiving medication for opioid use disorder and opioid overdose deaths during the early synthetic opioid crisis: A county-level analysis
Epidemiology [Epub 2024 Nov 22]. doi: 10.1097/EDE.0000000000001816.
Lim TY, Keyes KM, Caulkins JP, Stringfellow EJ, Cerda M, Jalali MS (2024).
Improving estimates of the prevalence of opioid use disorder in the United States: Revising Keyes et al
Journal of Addiction Medicine, 18 (6), 705-710. doi: 10.1097/ADM.0000000000001375.
Improving estimates of the prevalence of opioid use disorder in the United States: Revising Keyes et al
Journal of Addiction Medicine, 18 (6), 705-710. doi: 10.1097/ADM.0000000000001375.
Hasin DS, Mannes ZL, Livne O, Fink DS, Martins SS, Stohl M, Olfson M, Cerda M, Keyes KM, Keyhani S, Wisell CG, Bujno JM, Saxon A (2024).
Cannabis use and cannabis use disorder among US adults with psychiatric disorders: 2001-2002 and 2012-2013
Substance Use and Misuse [Epub 2024 Nov 12]. doi: 10.1080/10826084.2024.2423374.
Cannabis use and cannabis use disorder among US adults with psychiatric disorders: 2001-2002 and 2012-2013
Substance Use and Misuse [Epub 2024 Nov 12]. doi: 10.1080/10826084.2024.2423374.
Cerda M, Krawczyk N (2024).
The US overdose crisis: The next administration needs to move beyond criminalisation to a comprehensive public health approach
BMJ, 387, q2418. doi: 10.1136/bmj.q2418.
The US overdose crisis: The next administration needs to move beyond criminalisation to a comprehensive public health approach
BMJ, 387, q2418. doi: 10.1136/bmj.q2418.
Notable
Prescription drug monitoring programs and opioid overdoses: Exploring sources of heterogeneity
Epidemiology, 30 (2), 212-220. doi: 10.1097/EDE.0000000000000950. PMCID: PMC6437666.
Cerda M, Wall M, Feng T, Keyes KM, Sarvet A, Schulenberg J, O'Malley PM, Pacula RL, Galea S, Hasin DS (2017).
Association of state recreational marijuana laws with adolescent marijuana use
JAMA Pediatrics, 171 (2), 142-149. doi: 10.1001/jamapediatrics.2016.3624. PMCID: PMC5365078.
Dr. Cerdá's Google Scholar Profile
Selected Press